About Anophthalmia and Microphthalmia
Anophthalmia and microphthalmia are congenital diseases that affect the eyes. Anophthalmia is a disorder in which one or both eyes are small, and microphthalmia is the absence of one or both eyes. These disorders develop during pregnancy. There are various causes, including genetic mutations and abnormal chromosomes. Researchers also believe that environmental factors, such as exposure to X-rays, chemicals, drugs, pesticides, toxins, radiation, or viruses, with ongoing research in genetics and molecular biology, there may be developments in genetic therapies targeting the underlying causes of anophthalmia and microphthalmia. Gene therapies could potentially address the root causes of these conditions, presenting new treatment options.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
The market for Anophthalmia and Microphthalmia is relatively niche due to the rare nature of these conditions. Consequently, competition among pharmaceutical and medical device companies in this specific market may be limited compared to more prevalent medical conditions. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Pfizer (United States), Novartis AG (Switzerland), Cardinal Health (United States), Bristol-Myers Squibb Company. (United States), Valeant Pharmaceuticals International, Inc (Canada), Bayer AG (Germany), 3M (United States), EuroEyes (Germany), Aerie Pharmaceuticals, Inc. (United States), Alcon (Switzerland), Bausch Health Companies Inc (Canada), Johnson & Johnson Vision (United States), Hoya Corporation (Japan), Glaukos Corporation (United States), ZEISS Group International (Germany), TOPCON CORPORATION (Japan), NIDEK CO., LTD (United States) and Spark Therapeutics, Inc. (United States) are some of the key players that are part of study coverage.
Segmentation Overview
AMA Research has segmented the market of Global Anophthalmia and Microphthalmia market by , Application (Hospitals, Speciality Clinics, Research Center and Others) and Region.
On the basis of geography, the market of Anophthalmia and Microphthalmia has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Treatment, the sub-segment i.e. Surgical Interventions will boost the Anophthalmia and Microphthalmia market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Increasing adoption of Prosthetic eyes
Market Growth Drivers:
Growing awareness about congenital eye conditions and Advancement in ocular prosthetics, such as artificial eyes, can contribute to market growth.
Challenges:
High cost of treatment for anophthalmia and microphthalmia and Anophthalmia and microphthalmia can have genetic causes, and understanding the genetic basis of these conditions is complex
Restraints:
Treatment options for anophthalmia and microphthalmia are often limited
Opportunities:
Exploring treatments and therapies including, stem cell therapy, gene therapy, and tissue engineering
Market Leaders and their expansionary development strategies
In November 2022, Alcon, the global leader in eye care dedicated to helping people see brilliantly, acquired of Aerie Pharmaceuticals, Inc. The acquisition helps bolster Alcon’s presence in the ophthalmic pharmaceutical space with its growing portfolio of commercial products and development pipeline.
In February 2023, NIDEK CO LTD., a global leader in the design, manufacture, and distribution of ophthalmic, optometric, and lens edging equipment, launched of the Cube α Ophthalmic Surgical System. The Cube α incorporates Gyro torsional technology in a compact body. Torsional ultrasound oscillation ensures efficient delivery of ultrasound energy especially for moderate cataracts. Design enhancements increase surgical safety by protecting intraocular tissues.
Key Target Audience
End users’ industry, Research Organization, Government Regulatory and Others
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.